Study summary

The purpose of the study is to evaluate the safety and efficacy of FK463 in patients with proven or probable invasive infections due to Aspergillus species.

Additional Study Details

Phase
Phase 2
Product
  • FK463
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    326
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for Study of FK463 for the Treatment of Invasive Aspergillosis? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie
      Wurzburg, Germany, E-97070
      Completed
      LMU Munchen, Hamatopoetische Zell - Transplantation
      Munchen, Germany, D-81366
      Completed
      Westpfalz Krankehaus
      Kaiserslautern, Germany, D-67655
      Completed
      Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
      Leipzig, Germany, D-04103
      Completed
      Uniklinik Mainz
      Mainz, Germany, 55101
      Completed
      Royal Free Hospital, Dept. of Haematological Oncology
      London, United Kingdom, NW3 2QG
      Completed
      Hopital Saint Louis, Service D'Hematologie/Greffe de Moelle
      Paris, France, 10
      Completed
      Hopital Henri Mondor, Service d'Hematologie Clinique
      Creteil, France, 94010
      Completed
      Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera
      Milano, Italy, 20162
      Completed
      Hospital Clinic I provencial, Servicio Enfermadades Infecciosas
      Barcelona, Spain, ES 28041
      Completed
      Hospital Doce de Octubre, Servicio de Microbiologia y Enfermadades Infecciosas
      Madrid, Spain, ES 28041
      Completed
      Hospital Gregorio Maranon, Servicio de Enfermadades Infecciosas
      Madrid, Spain, ES 28007
      Completed
      Medizinische Univ.-Klinik
      Graz, Austria, 8036
      Completed
      Huddinge University Hospital, Dept. of Transplantation Surgery/Immunology
      Huddinge, Sweden, SE141 86
      Completed
      Nationale Institute for Cancer Research
      Genova, Italy, I 16132
      Completed
      Krankenhaus Elisabethinen Linz
      Linz, Austria, A-4010
      Completed
      Christie Hospital NHS Trust
      Manchester, United Kingdom, M20 4BX
      Completed
      Klinikum der Stadt, Medizinische Klinik A
      Ludwigshafen, Germany, D-67063
      Completed
      Johann Wolfgang Goethe Universitat, Medizinische Klinik III
      Frankfurt, Germany, D-60590
      Completed
      Royal Marsden Hospital
      Sutton Surrey, United Kingdom, SM2 5PT
      Completed
      Institute of Haematology and Blood Transfusion
      Warsaw, Poland, 00-957
      Completed
      Hopital Necker Enfants Malades, Service d'Hematologie
      Paris, France, 75015
      Completed
      Hotel Dieu, Service d'Hematologie
      Nantes, France, 44093

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?